Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression

de Wit, Meike; Jimenez, Connie R.; Carvalho, Beatriz; Belien, Jeroen A. M.; Delis-van Diemen, Pien M.; Mongera, Sandra; Piersma, Sander R.; Vikas, Maindad; Navani, Sanjay; Pontén, Fredrik; Meijer, Gerrit A.; Fijneman, Remond J. A.
June 2012
Gut;Jun2012, Vol. 61 Issue 6, p855
Academic Journal
Background and objective Early detection of colon adenomas at high risk of progression and early-stage colorectal cancer (CRC) is an effective approach to reduce CRC death rates. Current screening methods lack specificity as they detect many adenomas that will never progress to CRC. The authors aimed to identify cell surface protein biomarkers with extracellular domains that could be targeted for molecular imaging and discriminate low-risk adenomas and normal colon from high-risk adenomas and CRC. Design Cell surface proteins of five CRC cell lines were biotinylated, isolated and analysed by in-depth proteomics using gel electrophoresis and nanoliquid chromatography coupled to tandem mass spectrometry. Differential expression in adenomas and CRCs was based on mRNA expression and verified by immunohistochemical staining of tissue microarrays. Results In total, 2609 proteins were identified in the cell surface fractions. Of these, 44 proteins were selected as promising cell surface candidate biomarkers for adenoma-to-carcinoma progression based on the following criteria: protein identification in at least four out of five cell lines, a predicted (trans)membrane location and increased mRNA expression in CRCs compared to adenomas. Increased protein expression in high-risk adenomas and CRCs compared to low-risk adenomas was confirmed by immunohistochemistry for glucose transporter type 1 (gene symbol SLC2A1; p<0.00001) and prion protein (gene symbol PRNP; p<0.005). Conclusion This study revealed glucose transporter type 1, prion protein and 42 other cell surface candidate biomarkers for adenoma-to-carcinoma progression that could potentially serve as targets for emerging molecular imaging modalities like optical imaging, 19F-MRI and positron emission tomography. INSET: Significance of this study.


Related Articles

  • Cell Membrane Proteomic Analysis Identifies Proteins Differentially Expressed in Osteotropic Human Breast Cancer Cells. Kischel, Philippe; Guillonneau, François; Dumont, Bruno; Bellahcène, Akeila; Stresing, Verena; Clézardin, Philippe; De Pauw, Edwin A.; Castronovo, Vincent // Neoplasia;Sep2008, Vol. 10 Issue 9, p1014 

    Metastatic breast cancer cells are characterized by their high propensity to colonize the skeleton and form bone metastases, causing major morbidity and mortality. Identifying key proteins involved in the osteotropic phenotype would represent a major step toward the development of both new...

  • Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines. Zhiyu Zhang; Lijun Zhang; Yingqi Hua; Xiaofang Jia; Jian Li; Shuo Hu; Xia Peng; Pengyuan Yang; Mengxiong Sun; Fang Ma; Zhengdong Cai // BMC Cancer;2010, Vol. 10, p206 

    Background: Osteosarcoma (OS) is the most common primary malignant tumor of bone in children and adolescents. However, the knowledge in diagnostic modalities has progressed less. To identify new biomarkers for the early diagnosis of OS as well as for potential novel therapeutic candidates, we...

  • A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma. Stewart, Paul A.; Parapatics, Katja; Welsh, Eric A.; Müller, André C.; Cao, Haoyun; Fang, Bin; Koomen, John M.; Eschrich, Steven A.; Bennett, Keiryn L.; Haura, Eric B. // PLoS ONE;11/5/2015, Vol. 10 Issue 10, p1 

    We performed a pilot proteogenomic study to compare lung adenocarcinoma to lung squamous cell carcinoma using quantitative proteomics (6-plex TMT) combined with a customized Affymetrix GeneChip. Using MaxQuant software, we identified 51,001 unique peptides that mapped to 7,241 unique proteins...

  • Identification of Kininogen-1 as a Serum Biomarker for the Early Detection of Advanced Colorectal Adenoma and Colorectal Cancer. Wang, Jing; Wang, Xinying; Lin, Shiyong; Chen, Chudi; Wang, Congrong; Ma, Qunying; Jiang, Bo // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Background: Serum markers represent potential tools for the detection of colorectal cancer (CRC). The aim of this study was to obtain proteomic expression profiles and identify serum markers for the early detection of CRC. Methods: Proteomic profiles of serum samples collected from 35 healthy...

  • Potential biomarker identified for aggressive colon cancer.  // Medical Device Daily;6/7/2013, Vol. 17 Issue 110, Special section p2 

    The article reports on a study from the University of Texas MD Anderson Cancer Center in Houston, Texas, saying that MET protein levels correlate intensely with epithelial-mesenchymal transition phenotype, which is a treatment-resistant type of colorectal cancer and may be used as a surrogate...

  • Proteomics-Based Technologies in the Discovery of Biomarkers for Multiple Sclerosis in the Cerebrospinal Fluid. Louren�o, A. S. T.; Baldeiras, I.; Gr�os, M.; Duarte, C. B. // Current Molecular Medicine;Jun2011, Vol. 11 Issue 4, p326 

    Multiple Sclerosis is the most common non-traumatic disorder of the central nervous system and is generally regarded as an immune-mediated disorder that occurs in young adults. Since cerebrospinal fluid is in close contact with the extracellular surface of the brain, it is of great interest to...

  • Plasma membrane proteomic analysis of human Gastric Cancer tissues: revealing flotillin 1 as a marker for Gastric Cancer. Wen Gao; Jing Xu; Fuqiang Wang; Long Zhang; Rui Peng; Yongqian Shu; Jindao Wu; Qiyun Tang; Yunxia Zhu // BMC Cancer;Aug2015, Vol. 15 Issue 1, p1 

    Background: Gastric cancer remains the second leading cause of cancer-related deaths in the world. Successful early gastric cancer detection is hampered by lack of highly sensitive and specific biomarkers. Plasma membrane proteins participate and/or have a central role in the metastatic process...

  • Tools for phospho- and glycoproteomics of plasma membranes. Wiśniewski, Jacek // Amino Acids;Jul2011, Vol. 41 Issue 2, p223 

    nalysis of plasma membrane proteins and their posttranslational modifications is considered as important for identification of disease markers and targets for drug treatment. Due to their insolubility in water, studying of plasma membrane proteins using mass spectrometry has been difficult for a...

  • immunoselection.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1163 

    A definition of the term "immunoselection," which refers to the enhanced survival of cells or organizations with favorable cell surface markers is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics